Search

Your search keyword '"Bergh, Jonas"' showing total 1,423 results

Search Constraints

Start Over You searched for: Author "Bergh, Jonas" Remove constraint Author: "Bergh, Jonas"
1,423 results on '"Bergh, Jonas"'

Search Results

2. The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial

6. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

10. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

12. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

16. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

17. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

20. MNK2 governs the macrophage antiinflammatory phenotype

22. Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]Ga-ABY-025: Results from a Pilot Study

24. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

25. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

27. Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images

28. Breast cancer during pregnancy—The oncologist's point of view.

30. European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma

33. ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden—a phase III randomised double-blinded placebo-controlled study

35. Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study

37. A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer

38. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

41. Caring for patients with cancer in the COVID-19 era

43. Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

44. Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

50. RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

Catalog

Books, media, physical & digital resources